Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORWARD Trial: Febuxostat vs Allopurinol on Cardiovascular Risk Surrogate Markers in Gout
2014-005567-33Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in gout comparing Febuxostat arm with Allopurinol arm (2 arms). Primary endpoint: Pulse Wave Velocity change at 36 weeks. Started Mar 2015; status: completed.
02
Drugs
febuxostatallopurinol
03
Conditions
gout
Beyond the preview
Go deeper on 2014-005567-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005567-33.